Sort
40,608 grants matching “prostate cancer”
Bionanotechnology approach for treatment of lung cancer
$585,581Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2021 · CA
Bionanotechnology approach for treatment of lung cancer
$585,581Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2019 · CA
Bionanotechnology approach for treatment of lung cancer
$585,581Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2020 · CA
Administrative Core
$585,368Kate Taylor Shumate · University Of California, San Francisco · P30 · FY2025 · CA
Synthesis Directed Toward Therapeutic Agents
$585,282Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R01 · FY2014 · GM
Synthesis Directed Toward Therapeutic Agents
$585,282Derek S Tan · Sloan-Kettering Inst Can Research · R01 · FY2015 · GM
Synthesis Directed Toward Therapeutic Agents
$585,280Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R01 · FY2012 · GM
Metabolic Targets in Pten-Tumors
$585,248Jeffrey A Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2009 · CA
Project 1: Design Rules for Spherical Nucleic Acids that Target Cancer
$585,205Milan Mrksich · Northwestern University At Chicago · U54 · FY2017 · CA
Genetics Variants in the Genome Predisposing to Aggressive PCa
$585,183William B Isaacs · Johns Hopkins University · R01 · FY2011 · CA
A proteomic approach for early diagnosis of diabetes
$585,155Julian D Watts · Institute For Systems Biology · R33 · FY2007 · DK
Computerized histologic image predictor of cancer outcome
$585,112Anant Madabhushi · Case Western Reserve University · R01 · FY2019 · CA
OBSTRUCTING ANDROGEN RECEPTOR ACTIVATION IN PROSTATE CANCER CELLS THROUGH POSTTRANSLATIONAL MODIFICATION BY NEDD8
$585,000Umdnj-Robert Wood Johnson Medical School · · FY2008 · Department of the Army
PRECLINICAL STUDIES OF SIGNALING PATHWAYS IN A MUTANT MOUSE MODEL OF HORMONE-REFRACTORY PROSTATE CANCER
$585,000The Trustees Of Columbia University In The City Of New York · · FY2008 · Department of the Army
TARGETING SIAH2 AS NOVEL THERAPY FOR METASTATIC PROSTATE CANCER
$585,000Sanford Burnham Prebys Medical Discovery Institute · · FY2014 · Department of Defense
SENSITIZATION OF PROSTATE CANCER CELLS TO ANTIANDROGEN THERAPY USING SELECTIVE RXR MODULATORS
$585,000Duke University · · FY2009 · Department of the Army
TARGETING SURVIVIN TO OVERCOME ACQUIRED TAXOL RESISTANCE IN PROSTATE CANCER CHEMOTHERAPY
$584,998Trustees Of Indiana University · · FY2014 · Department of Defense
HEROIC PROSTATE CANCER PRECISION HEALTH (PCAPH) AFRICA1K: POWERING PRECISION HEALTH TO IMPROVE PROSTATE CANCER OUTCOMES IN AFRICA
$584,828University Of Nairobi · · FY2024 · Defense Health Agency
De-implementation of low value castration for men with prostate cancer
$584,825Sameer Dev Saini · University Of Michigan At Ann Arbor · R37 · FY2023 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$584,740Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Emory, Harvard & Univ. of Washington Prostate Cancer Biomarker Center
$584,697Martin G Sanda · Emory University · U01 · FY2021 · CA
Biomaterials (Mf/Zn/F-BCPs) for osteoporosis therapy
$584,688Yu Zhang · New York University · R01 · FY2012 · AR
Smart template for prostate biopsy guidance
$584,624Jesung Park · Physical Sciences, Inc · R44 · FY2020 · CA
Mitochondrial Dynamics in RPE Homeostasis and Disease
$584,619Scott M Plafker · Oklahoma Medical Research Foundation · R01 · FY2019 · EY
Combined ATR and P13k inhibition in uterine cancer
$584,483Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P01 · FY2024 · CA